DCVA Annual Plan 2022Detecting cardiovascular disease before it strikes
With 2021 at an end, it's time to look forward. What are the plans of the Dutch CardioVascular Alliance in 2022? Find out now!
“Working with others is just more enjoyable”
Professor Wiek van Gilst will be resigning as the DCVA executive chairman. How does he look back on his work and in what way is the establishment of the DCVA the crowning achievement of his career?
Vision digital cardiovascular healthcare
Last year, seven partners of the DCVA joined forces to develop a vision document about digital cardiovascular healthcare.
Professor Jolien Roos-Hesselink new managing-director DCVA
Prof. dr. Jolien Roos-Hesselink, a cardiologist affiliated with the Erasmus Medical Center Rotterdam and Radboud University Medical Center Nijmegen, will be the new managing-director of the Dutch CardioVascular Alliance (DCVA). She will succeed Prof. Wiek van Gilst. The supervisory board of the DCVA announced this today.
DCVA Leadership Program 2021-2022
Join the nationwide study into myocardial damage after COVID-19
Successful 5th DCVA Translational Cardiovascular Research Meeting
Annual report 2020 of the Netherlands Heart Registration (NHR)
International funders to work hand in hand to improve global heart health
Preclinicaltrials.eu: new daily director and new activities for the animal registry.
Results COVID@HEART: cardiovascular patients more at risk of hospitalization with COVID-19
One year DCVA Leadership Program
“Registry-based research is not a plaything for academics but a bridge between science and practice”
Few, but severe strokes in hospitalised COVID-19 patientsRemarkable: patients did not have a greater risk of cardiovascular disease beforehand
"Fast results of COVID-19 research thanks to close cooperation within the DCVA"
Severe heart failure increases mortality risk in COVID-19 patients
Call for registry-based research
Additional study into COVID-19-care by general practitioner
The study, which is an extension of the DCVA COVID@HEART study, is focused on people who get COVID-19 but are not hospitalized.